Page last updated: 2024-09-05

4-hydroxyalprazolam and alpha-hydroxyalprazolam

4-hydroxyalprazolam has been researched along with alpha-hydroxyalprazolam in 5 studies

Compound Research Comparison

Studies
(4-hydroxyalprazolam)
Trials
(4-hydroxyalprazolam)
Recent Studies (post-2010)
(4-hydroxyalprazolam)
Studies
(alpha-hydroxyalprazolam)
Trials
(alpha-hydroxyalprazolam)
Recent Studies (post-2010) (alpha-hydroxyalprazolam)
7122639

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, RJ; Gall, M; Kamdar, BV1
Allqvist, A; Bertilsson, L; Gustafsson, LL; Mirghani, RA; Svensson, JO; Wennerholm, A1
Allqvist, A; Bertilsson, L; Mirghani, RA; Miura, J1
Honda, K; Nakamura, T; Shinozuka, T; Tanaka, E; Terada, M1
Bertilsson, L; Carrero, JJ; Diczfalusy, U; Heimbürger, O; Lindholm, B; Molanaei, H; Odar-Cederlöf, I; Qureshi, AR; Stenvinkel, P1

Trials

1 trial(s) available for 4-hydroxyalprazolam and alpha-hydroxyalprazolam

ArticleYear
Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.
    European journal of clinical pharmacology, 2005, Volume: 61, Issue:2

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Oxidoreductases, N-Demethylating

2005

Other Studies

4 other study(ies) available for 4-hydroxyalprazolam and alpha-hydroxyalprazolam

ArticleYear
Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines.
    Journal of medicinal chemistry, 1978, Volume: 21, Issue:12

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Hydroxylation; Male; Methods; Mice; Oxidation-Reduction; Triazolam; Triazoles

1978
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Antifungal Agents; Antimalarials; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Inhibitory Concentration 50; Ketoconazole; Mass Spectrometry; Microsomes, Liver; Quinidine; Stereoisomerism

2007
Metabolic interaction between ethanol, high-dose alprazolam and its two main metabolites using human liver microsomes in vitro.
    Journal of forensic and legal medicine, 2007, Volume: 14, Issue:6

    Topics: Alprazolam; Anti-Anxiety Agents; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Forensic Toxicology; Humans; In Vitro Techniques; Microsomes, Liver

2007
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
    European journal of clinical pharmacology, 2012, Volume: 68, Issue:5

    Topics: Adult; Aged; Algorithms; Alprazolam; Anti-Anxiety Agents; Biomarkers; Biotransformation; C-Reactive Protein; Cytochrome P-450 CYP3A; Female; Humans; Hydroxycholesterols; Hydroxylation; Male; Middle Aged; Orosomucoid; Renal Dialysis; Renal Insufficiency, Chronic

2012